Atopic dermatitis, commonly called eczema, is a chronic inflammatory skin condition affecting over 31 million Americans. Despite its prevalence, many patients struggle to find effective long-term treatment.
Common Symptoms
- Intense itching, especially at night
- Red, inflamed patches of skin
- Dry, sensitive, cracked skin
- Recurring rashes that may ooze or crust
- Thickened or scaly skin in affected areas
Common Triggers
Eczema flares are often triggered by dry weather, certain soaps or detergents, synthetic fabrics, sweat, stress, pet dander, dust mites, and certain foods. Identifying and avoiding personal triggers can significantly reduce flare frequency.
The Itch-Scratch Cycle
One of the most frustrating aspects of eczema is the itch-scratch cycle. Scratching damaged skin worsens inflammation, which causes more itching, creating a destructive loop that disrupts sleep and quality of life.
How Clinical Trials Are Helping
Research in atopic dermatitis has accelerated dramatically in recent years. Investigators are studying biologics, JAK inhibitors, and novel topical agents that target specific inflammatory pathways, offering new hope for patients with moderate-to-severe disease.
Participate at NuLine
NuLine Clinical Trial Center in Oakland Park is currently enrolling participants ages 12 and older with moderate-to-severe atopic dermatitis. All study-related care is provided at no cost. Learn more about our eczema study.